Truvada, aka PrEP, to Be Sold in Generic Form by September 2020 - TicToc by Bloomberg

A generic version of the HIV prevention pill Truvada will be available in the United States by September 2020, a year earlier than expected, according to Gilead Sciences.

When taken daily, Truvada prevents HIV transmission. This approach is called HIV pre-exposure prophylaxis (PrEP).

"Gilead reached an agreement with Teva Pharmaceuticals in 2014 to allow the early launch of a generic version of Truvada into the market in 2020, a year earlier than required," Douglas Brooks, Gilead's executive director for community engagement, wrote in an email shared with NBC News by the advocacy group PrEP4All.

A month's supply of generic Truvada is available in countries around the world for as little as $70, but the drug costs $1,600 to $2,000 in the United States.

Activists launched a campaign to convince Gilead to make the generic drug more widely available to combat the global HIV epidemic.

Subscribe to our YouTube channel: https://bit.ly/2TwO8Gm

TICTOC ON SOCIAL:
Follow TicToc on Twitter: https://twitter.com/tictoc
Like TicToc on Facebook: https://www.facebook.com/tictoc
Follow TicToc on Instagram: https://www.instagram.com/tictoc

Watch all of TicToc’s videos: https://www.tictoc.video/

Listen to TicToc’s podcast: https://apple.co/2D3Vta7
Subscribe to our newsletter: https://bit.ly/2FJ0oQZ

TicToc by Bloomberg is global news for the life you lead. We are a 24/7 news network that covers breaking news, politics, technology, business and entertainment stories from around the globe, supported by a network of Bloomberg’s 2,700 journalists across 120 countries.